Blumberg Pharmaceuticals Private Limited, a active private limited company, was established on 17 July 2019 in Gmc, Assam, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24299AS2019PTC019374. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Biplob Roy (Director), Santosh Kumar (Director), Debabrata Singha (Director). Past directors included Gayatri Devi Pandit, Sanjay Kumar Pandit, Biplob Roy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H/No. 9, Bhakti Vijay Bhawan, Shishuram Choudhary Path, Bhairabtala, Kalaphar, Gmc, Assam, 781018.
U24299AS2019PTC019374
019374
17 July 2019
₹1.50 M
₹1.50 M
Roc Guwahati
Unlisted
Active
Explore comprehensive insights into Blumberg Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Biplob Roy | Director | 20 Oct 2020 | Current |
| Santosh Kumar | Director | 20 Oct 2020 | Current |
| Debabrata Singha | Director | 06 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Aug 2024 | Past |
| Pramod Abcsdd | Director | 19 Aug 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Blumberg Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.13% increase. The company also saw a substantial improvement in profitability, with a 13.26% increase in profit. The company's net worth Soared by an impressive increase of 39.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Blumberg Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Blumberg Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Blumberg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blumberg Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Blumberg Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Blumberg Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was completed.
Debabrata Singha was appointed as a Director was appointed as a Director on 06 Oct 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
Progress on Biplob Roy was appointed as a Director was appointed as a Director on 20 Oct 2020 & has been associated with this company since 5 years 1 month . was documented.
The activity Santosh Kumar was appointed as a Director was appointed as a Director on 20 Oct 2020 & has been associated with this company since 5 years 1 month . was completed.
Progress on Blumberg Pharmaceuticals Private Limited was registered on 17 Jul 2019 with Roc Guwahati & aged 6 years 4 months as per MCA records. was documented.
The CIN of Blumberg Pharmaceuticals Private Limited is U24299AS2019PTC019374.
Blumberg Pharmaceuticals Private Limited is headquartered at H/No. 9, Bhakti Vijay Bhawan, Shishuram Choudhary Path, Bhairabtala, Kalaphar, Gmc, Assam, 781018.
Blumberg Pharmaceuticals Private Limited was incorporated on 17 July 2019.
The current directors of Blumberg Pharmaceuticals Private Limited are
The primary industry of Blumberg Pharmaceuticals Private Limited is Manufacturing.
Blumberg Pharmaceuticals Private Limited is unlisted.
The authorized capital of Blumberg Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX